Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?

Q3 Medicine
Acta Medica Lituanica Pub Date : 2022-01-01 Epub Date: 2022-06-29 DOI:10.15388/Amed.2022.29.1.18
Mindaugas Stankūnas, Kersti Pärna, Anna Tisler, Anda Ķīvīte-Urtāne, Una Kojalo, Jana Zodzika, Nicholas Baltzer, Jan Nygard, Mari Nygard, Anneli Uuskula
{"title":"Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?","authors":"Mindaugas Stankūnas,&nbsp;Kersti Pärna,&nbsp;Anna Tisler,&nbsp;Anda Ķīvīte-Urtāne,&nbsp;Una Kojalo,&nbsp;Jana Zodzika,&nbsp;Nicholas Baltzer,&nbsp;Jan Nygard,&nbsp;Mari Nygard,&nbsp;Anneli Uuskula","doi":"10.15388/Amed.2022.29.1.18","DOIUrl":null,"url":null,"abstract":"<p><p>The three Baltic States (Estonia, Latvia, and Lithuania) are among the European Union countries with the highest incidence and mortality rates for cervical cancer. In order to tackle this public health challenge, there is an urgent need to implement more advanced and effective methods in cervical cancer prevention in Baltic countries. Nationwide cervical cancer screening programs in the Baltic States commenced in 2004-2009. While the organized screening programs in these countries differ in some relevant details (target age groups, screening interval), the underlying principles and problems, barriers are universal. However, the outcomes of present screening programs are unsatisfactory. In addition, universal screening programs are extremely costly. There is a potential need for more intelligent and personalized cervical cancer screening program. In 2019 the project <i>\"Towards elimination of cervical cancer: intelligent and personalized solutions for cancer screening\"</i> (2020-2023) was developed with the main objective - to develop improved and personalized cancer screening methods within a sustainable health care system. It is expected, that more sophisticated cervical cancer screening model will be implemented in Estonia, Latvia, and Lithuania, and will have a positive impact to epidemiology of cervical cancer and public health in general.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"29 1","pages":"19-26"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428648/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Lituanica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15388/Amed.2022.29.1.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

The three Baltic States (Estonia, Latvia, and Lithuania) are among the European Union countries with the highest incidence and mortality rates for cervical cancer. In order to tackle this public health challenge, there is an urgent need to implement more advanced and effective methods in cervical cancer prevention in Baltic countries. Nationwide cervical cancer screening programs in the Baltic States commenced in 2004-2009. While the organized screening programs in these countries differ in some relevant details (target age groups, screening interval), the underlying principles and problems, barriers are universal. However, the outcomes of present screening programs are unsatisfactory. In addition, universal screening programs are extremely costly. There is a potential need for more intelligent and personalized cervical cancer screening program. In 2019 the project "Towards elimination of cervical cancer: intelligent and personalized solutions for cancer screening" (2020-2023) was developed with the main objective - to develop improved and personalized cancer screening methods within a sustainable health care system. It is expected, that more sophisticated cervical cancer screening model will be implemented in Estonia, Latvia, and Lithuania, and will have a positive impact to epidemiology of cervical cancer and public health in general.

波罗的海国家的宫颈癌:智能和个性化的癌症筛查能改变这种状况吗?
波罗的海三国(爱沙尼亚、拉脱维亚和立陶宛)是宫颈癌发病率和死亡率最高的欧洲联盟国家之一。为了应对这一公共卫生挑战,波罗的海国家迫切需要在预防宫颈癌方面采用更先进和更有效的方法。2004-2009年,波罗的海国家启动了全国范围的宫颈癌筛查方案。虽然这些国家有组织的筛查计划在一些相关细节(目标年龄组、筛查间隔)上有所不同,但基本原则和问题、障碍是普遍存在的。然而,目前的筛查方案的结果并不令人满意。此外,普遍筛查项目非常昂贵。有一个潜在的需求,更智能和个性化的宫颈癌筛查计划。2019年,制定了“迈向消除宫颈癌:智能和个性化癌症筛查解决方案”(2020-2023年)项目,其主要目标是在可持续的医疗保健系统内开发改进的个性化癌症筛查方法。预计将在爱沙尼亚、拉脱维亚和立陶宛实施更先进的宫颈癌筛查模式,并将对宫颈癌流行病学和一般公共卫生产生积极影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Medica Lituanica
Acta Medica Lituanica Medicine-General Medicine
CiteScore
0.70
自引率
0.00%
发文量
33
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信